1h Free Analyst Time
The dna synthesis market is forecasted to grow by USD 6.52 billion during 2023-2028, accelerating at a CAGR of 18.1% during the forecast period. The report on the dna synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing use of DNA synthesis-based therapeutics, technological innovations in DNA synthesis, and rising prominence of PCR solutions in biomedical sector.
The dna synthesis market is segmented as below:
By Type
- Oligonucleotide synthesis
- Gene synthesis
By End-user
- Biopharmaceutical companies
- Academic and research institutes
- Contract research organizations and others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the dna synthesis market covers the following areas:
- Dna synthesis market sizing
- Dna synthesis market forecast
- Dna synthesis market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global dna synthesis market: Azenta US, Inc, Bio Basic Inc., BioCat GmbH, Biomatik Corp., Bioneer Corp., Danaher Corp., DNA Script, Epoch Life Science, Eton Bioscience Inc., Eurofins Scientific SE, Evonetix Ltd, Gene Universal, Inc., Genemed Synthesis Inc., GenScript Biotech Corp., OriGene Technologies Inc., ProMab Biotechnologies, Inc, Proteo Genix, Synbio Technologies LLC, Thermo Fisher Scientific Inc., and Twist Bioscience Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of automation in DNA synthesis."
According to the report, one of the major drivers for this market is the increasing use of DNA synthesis-based therapeutics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Azenta US Inc
- Bio Basic Inc.
- BioCat GmbH
- Biomatik Corp.
- Bioneer Corp.
- Danaher Corp.
- DNA Script
- Epoch Life Science
- Eton Bioscience Inc.
- Eurofins Scientific SE
- Evonetix Ltd
- Gene Universal Inc.
- Genemed Synthesis Inc.
- GenScript Biotech Corp.
- OriGene Technologies Inc.
- ProMab Biotechnologies Inc
- Proteo Genix
- Synbio Technologies LLC
- Thermo Fisher Scientific Inc.
- Twist Bioscience Corp.
